Serum Institute to apply for trials on Oxford's Covid-19 vaccine soon: CEO

With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Serum Institute of India (SII) on Monday said it will apply for licence from the Indian regulator to start clinical trials of the shot in a week's time.

SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

Earlier, Pune-based SII had said that it will start manufacturing the vaccine even before the final nod so as to be ready with sizeable volumes once the vaccine gets all permissions.